BCPE Perseus Investor, LP 13D and 13G filings for Kailera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-23 7:34 pm Purchase | 2026-04-16 | 13D | KAILERA THERAPEUTICS INC KLRA | BCPE Perseus Investor, LP | 26,255,581 20.270% | 26,255,581 (New Position) | Filing |